Josamicina: differenze tra le versioni

Versione delle 21:16, 3 giu 2012

Versione delle 21:19, 3 giu 2012

Riga 47:

L'antibiotico è indicato nelle [[infezioni]] sostenute da germi sensibili.<br>

La josamicina è stata utilizzata in infezioni broncopolmonari,<ref name=Kobayashi1>{{cite journal |author=Kobayashi Y, Akaishi K, Nishio T, Aihara M |title=[Josamycin propionate in the treatment of acute respiratory infections in children] |language=Japanese |journal=Jpn J Antibiot |volume=26 |issue=3 |pages=267–76 |year=1973 |month=June |pmid=4542549 |doi= |url=}}</ref><ref name=Iakovlev1>{{cite journal |author=Iakovlev SV, Aleksandrova MA, Suvorova MP, Kostina SA |title=[Evaluation of efficacy and safety of josamycin (Vilprafen) in the treatment of patients with community-acquired pneumonia] |language=Russian |journal=Antibiot. Khimioter. |volume=51 |issue=3-4 |pages=47–8, 50–2 |year=2006 |pmid=17165259 |doi= |url=}}</ref>otorinolaringoiatriche,<ref name=Kerschbaum1>{{cite journal |author=Kerschbaum H, Moritz AJ |title=[Josamycin in bronchopulmonary and otorhinological diseases in pediatrics] |language=German |journal=Padiatr Padol |volume=18 |issue=4 |pages=403–8 |year=1983 |pmid=6646791 |doi= |url=}}</ref> oftalmiche, stomatologiche,<ref name=Lagarrigue1>{{cite journal |author=Lagarrigue J |title=[Josamycin in oral-dental infections] |language=French |journal=Chir Dent Fr |volume=52 |issue=159 |pages=35–8 |year=1982 |month=May |pmid=6961989 |doi= |url=}}</ref><ref name=Beltrame1>{{cite journal |author=Beltrame M, Dazzi P, Baldin C, Musola L |title=[Use of josamycin in infections of the oral cavity] |language=Italian |journal=Dent Cadmos |volume=52 |issue=12 |pages=115, 119–20, 122 |year=1984 |month=December |pmid=6598783 |doi= |url=}}</ref> cutanee<ref name=Kiss1>{{cite journal |author=Kiss Z |title=[Experiences with josamycin therapy in dermatologic diseases] |language=Hungarian |journal=Orv Hetil |volume=141 |issue=19 |pages=1015–7 |year=2000 |month=May |pmid=10846423 |doi= |url=}}</ref><ref name=>{{cite journal |author=Nohara N, Akagi O, Kanzaki H, ''et al.'' |title=[Comparative clinical study of roxithromycin and josamycin for suppurative skin and soft tissue infections by a double-blind method] |language=Japanese |journal=Kansenshōgaku Zasshi |volume=63 |issue=3 |pages=203–27 |year=1989 |month=March |pmid=2504834 |doi= |url=}}</ref> e dei tessuti molli, urologiche,<ref name=Bartolotta1>{{cite journal |author=Bartolotta G, Amico F, Siragusa A |title=[Josamycin in urologic infections] |language=Italian |journal=G Ital Chemioter |volume=29 Suppl 1 |issue= |pages=175–80 |year=1982 |pmid=6927115 |doi= |url=}}</ref> <ref name=Lazzaro1>{{cite journal |author=Lazzaro A, Vettori G, Bagozzi B |title=[Clinical use of josamycin in comparison with erythromycin in respiratory and urinary tract infections] |language=Italian |journal=Clin Ter |volume=114 |issue=6 |pages=469–73 |year=1985 |month=September |pmid=3905221 |doi= |url=}}</ref>dell'[[apparato genitale]], della [[ghiandola mammaria]] e delle [[vie biliari]].<br>

E' stata inoltre utilizzata per il trattamento della [[febbre bottonosa]], sostenuta dalla [[Rickettsia conori]].<ref name=Bella1>{{cite journal |author=Bella F, Font B, Uriz S, ''et al.'' |title=Randomized trial of doxycycline versus josamycin for Mediterranean spotted fever |journal=Antimicrob. Agents Chemother. |volume=34 |issue=5 |pages=937–8 |year=1990 |month=May |pmid=2193627 |pmc=171727 |doi= |url=}}</ref>

==Posologia e vie di somministrazione==